CN106093441B - 一种孤独症血清糖蛋白标记物的用途 - Google Patents
一种孤独症血清糖蛋白标记物的用途 Download PDFInfo
- Publication number
- CN106093441B CN106093441B CN201610601323.5A CN201610601323A CN106093441B CN 106093441 B CN106093441 B CN 106093441B CN 201610601323 A CN201610601323 A CN 201610601323A CN 106093441 B CN106093441 B CN 106093441B
- Authority
- CN
- China
- Prior art keywords
- autism
- serum
- glycoprotein
- asd
- purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010003805 Autism Diseases 0.000 title claims abstract description 35
- 208000020706 Autistic disease Diseases 0.000 title claims abstract description 35
- 210000002966 serum Anatomy 0.000 claims abstract description 40
- 239000000910 agglutinin Substances 0.000 claims abstract description 14
- 101710088235 Envelope glycoprotein C homolog Proteins 0.000 claims abstract description 13
- 101710186708 Agglutinin Proteins 0.000 claims abstract description 11
- 101710146024 Horcolin Proteins 0.000 claims abstract description 11
- 101710189395 Lectin Proteins 0.000 claims abstract description 11
- 101710179758 Mannose-specific lectin Proteins 0.000 claims abstract description 11
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims abstract description 11
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims abstract description 11
- OVRNDRQMDRJTHS-KEWYIRBNSA-N N-acetyl-D-galactosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-KEWYIRBNSA-N 0.000 claims description 3
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 102000007592 Apolipoproteins Human genes 0.000 claims description 2
- 108010071619 Apolipoproteins Proteins 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 102000007562 Serum Albumin Human genes 0.000 claims 1
- 108010071390 Serum Albumin Proteins 0.000 claims 1
- 102000004856 Lectins Human genes 0.000 abstract description 14
- 108090001090 Lectins Proteins 0.000 abstract description 14
- 239000002523 lectin Substances 0.000 abstract description 14
- 238000003745 diagnosis Methods 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 238000001228 spectrum Methods 0.000 abstract description 5
- 102000003886 Glycoproteins Human genes 0.000 description 16
- 108090000288 Glycoproteins Proteins 0.000 description 16
- 238000009396 hybridization Methods 0.000 description 12
- 238000001514 detection method Methods 0.000 description 7
- 239000011324 bead Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000009333 Apolipoprotein D Human genes 0.000 description 2
- 108010025614 Apolipoproteins D Proteins 0.000 description 2
- 208000002109 Argyria Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 101100110009 Caenorhabditis elegans asd-2 gene Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000035976 Developmental Disabilities Diseases 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 101100110007 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) asd-1 gene Proteins 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000029560 autism spectrum disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000036630 mental development Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610601323.5A CN106093441B (zh) | 2016-07-27 | 2016-07-27 | 一种孤独症血清糖蛋白标记物的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610601323.5A CN106093441B (zh) | 2016-07-27 | 2016-07-27 | 一种孤独症血清糖蛋白标记物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106093441A CN106093441A (zh) | 2016-11-09 |
CN106093441B true CN106093441B (zh) | 2017-10-20 |
Family
ID=57449419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610601323.5A Active CN106093441B (zh) | 2016-07-27 | 2016-07-27 | 一种孤独症血清糖蛋白标记物的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106093441B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107796946B (zh) * | 2017-10-20 | 2019-10-25 | 中国医学科学院基础医学研究所 | 尿液中冠心病的蛋白标志物及其用途 |
CN109946447A (zh) * | 2019-03-13 | 2019-06-28 | 深圳大学 | 一种用于检测孤独症谱系障碍的诊断标志物、设备及应用 |
CN110045125B (zh) * | 2019-04-03 | 2022-08-09 | 中国医学科学院北京协和医院 | 一种用于诊断腹膜后纤维化的生物标志物及其用途 |
CN111471759B (zh) * | 2020-05-08 | 2021-11-19 | 西安交通大学 | 一种孤独症血清神经元来源外泌体标志物ostc的应用 |
CN114457153A (zh) * | 2022-03-15 | 2022-05-10 | 西安交通大学 | 一种孤独症血清神经元来源外泌体标志物chrm1的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0521098D0 (en) * | 2005-10-18 | 2005-11-23 | Univ Cambridge Tech | Methods for diagnosing and monitoring psychotic disorders |
AU2006303026A1 (en) * | 2005-10-18 | 2007-04-26 | Psynova Neurotech Limited | Methods and biomarkers for diagnosing and monitoring psychotic disorders such as schizophrenia |
CN105699658B (zh) * | 2016-01-28 | 2017-11-21 | 深圳大学 | 一种孤独症检测标志物及其检测方法 |
CN105652019B (zh) * | 2016-02-22 | 2017-10-20 | 西安交通大学 | 一种孤独症血清多肽标志物apoc1‑a及其应用 |
-
2016
- 2016-07-27 CN CN201610601323.5A patent/CN106093441B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106093441A (zh) | 2016-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106093441B (zh) | 一种孤独症血清糖蛋白标记物的用途 | |
US20210132060A1 (en) | Medical apparatus for testing for medical conditions including zika and pregnancy | |
Matos et al. | A new index to discriminate between iron deficiency anemia and thalassemia trait | |
Mens et al. | Direct blood PCR in combination with nucleic acid lateral flow immunoassay for detection of Plasmodium species in settings where malaria is endemic | |
US9857373B1 (en) | Pregnancy test to assess disease risk | |
Faramarzi et al. | Validation of nutritional risk index method against patient-generated subjective global assessment in screening malnutrition in colorectal cancer patients | |
CN104142399B (zh) | 一种利用胶体金免疫层析技术定量检测血清胃蛋白酶原的试纸条及其制备方法和应用 | |
Li et al. | Driverless artificial intelligence framework for the identification of malignant pleural effusion | |
CN107271693A (zh) | 一种快速便隐血双联检试纸条及其制备方法 | |
Mohammadian et al. | Evaluating reliability and predictive validity of the Persian Translation of Quantitative Checklist for Autism in Toddlers (Q-CHAT) | |
CN106687812A (zh) | 用于分析血液样品中的葡萄糖‑6‑磷酸脱氢酶活性的方法和组合物 | |
Krishnan et al. | Evaluation of total and lipid bound sialic acid in serum in oral leukoplakia | |
CN101344526A (zh) | 一种快速、精确的前列腺癌的检测试纸条及其制备和应用 | |
CN108796074A (zh) | 检测环状RNA circRNF13的试剂在制备肿瘤辅助诊断制剂上的应用及试剂盒 | |
Shin | Unexpected red cell antibody detection by conditional combination of LISS/Coombs and NaCl/Enzyme gel tests at a tertiary care hospital in Korea: a 5-year study | |
CN110488012A (zh) | 一种新生儿肺炎的辅助诊断试剂盒及应用 | |
Ott et al. | Basophil activation test for the diagnosis of hymenoptera venom allergy in childhood: a pilot study | |
WO2018210395A1 (en) | Lateral flow chromatographic assay for tuberculosis (tb) | |
CN103512972A (zh) | 精神分裂症的生物标志物及其使用方法和应用 | |
EP2812694A2 (en) | Assays and methods for the diagnosis of ovarian cancer | |
CN110993092A (zh) | 一种基于n-糖指纹图谱和大数据算法鉴别肝硬化及肝癌的方法 | |
Emanuel | In vitro testing for allergy diagnosis | |
CN103675293A (zh) | Rv3872、Rv0164和/或Rv1926c蛋白在制备诊断活动性肺结核的产品中的用途 | |
Godwin et al. | PREVALENCE OF MALARIA USING TWO RAPID DIAGNOSTIC TEST KIT IN THE DIAGNOSIS OF MALARIA IN GOMBE STATE, NIGERIA. | |
Shang et al. | Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190417 Address after: 511400 No. 98 Huaan West Street, Fujian Road, Qiaonan Street, Panyu District, Guangzhou City, Guangdong Province 101 Patentee after: Guangzhou Chenhui Biomedical Technology Co.,Ltd. Address before: No. 28 Xianning West Road, Xianning stele area, Xi'an, Shaanxi Patentee before: Xi'an Jiaotong University |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 528000 No. 1405, 1406, 1407 and 1408, 14 / F, block 4, gaojun scientific and technological innovation center, No. 1, Chaogui South Road, xiaohuangpu community, Ronggui street, Shunde District, Foshan City, Guangdong Province (residence declaration) Patentee after: Guangdong Chenhui Biomedical Technology Co.,Ltd. Address before: 511400 No. 98 Huaan West Street, Fujian Road, Qiaonan Street, Panyu District, Guangzhou City, Guangdong Province 101 Patentee before: Guangzhou Chenhui Biomedical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231025 Address after: 529200 Commercial and Residential Building 201, Shop 08, No. 1 Fenghuang Street, Country Garden, Taishan City, Jiangmen City, Guangdong Province (multiple photos of one site) Patentee after: Guangdong Qiaoduhui Medical Technology Co.,Ltd. Address before: 528000 No. 1405, 1406, 1407 and 1408, 14 / F, block 4, gaojun scientific and technological innovation center, No. 1, Chaogui South Road, xiaohuangpu community, Ronggui street, Shunde District, Foshan City, Guangdong Province (residence declaration) Patentee before: Guangdong Chenhui Biomedical Technology Co.,Ltd. |